Inflammation, pain, and chronic disease: An integrative approach to treatment and prevention

Alternative Therapies in Health and Medicine

Volumn 11, Issue 6, 2005, Pages 20-27

  Edwards, Tanya ^a,b,c  

^a Center for Integrative Medicine   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Inno Vision Communications   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTHOCYANIN; ANTHOXANTHINE; ASCORBIC ACID; CATECHIN; CURCUMIN; EPIGALLOCATECHIN GALLATE; ESSENTIAL FATTY ACID; FISH OIL; FLAVAN DERIVATIVE; FLAVANOL; FLAVANOL DERIVATIVE; FLAVONE DERIVATIVE; FLAVONOID; GINGER EXTRACT; ISOFLAVONE DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PETASITES HYBRIDUS EXTRACT; PLANT EXTRACT; POLYPHENOL; RETINOL; SELENIUM; TANACETUM PARTHENIUM EXTRACT; UNCLASSIFIED DRUG; XANTHINE DERIVATIVE; ANTIOXIDANT; NEUROPROTECTIVE AGENT; VITAMIN;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ATHEROSCLEROSIS; BODY FAT; BRAIN DISEASE; BUTTERBUR; CANCER; CANCER MODEL; CARDIOVASCULAR DISEASE; CELL SURVIVAL; CHRONIC DISEASE; CHRONIC INFLAMMATION; DIABETES MELLITUS; DIET SUPPLEMENTATION; DIETARY FIBER; DIETARY INTAKE; EXERCISE; FAT INTAKE; FOOD CHAIN; FRUIT; FRUIT JUICE; GASTROINTESTINAL DISEASE; GINGER; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INFLAMMATION; INTEGRATIVE MEDICINE; LIFESTYLE; MEDICINAL PLANT; METABOLIC SYNDROME X; MORBIDITY; MORTALITY; NONHUMAN; OBESITY; OSTEOARTHRITIS; OXIDATIVE STRESS; PAIN; POMEGRANATE; PROSTATE TUMOR; REVIEW; SIGNAL TRANSDUCTION; TANACETUM PARTHENIUM; TEA; VEGETABLE; INTEGRATED HEALTH CARE SYSTEM; NEOPLASM; PRIMARY PREVENTION; RISK REDUCTION; STANDARD;

ANTIOXIDANTS; CARDIOVASCULAR DISEASES; CHRONIC DISEASE; DELIVERY OF HEALTH CARE, INTEGRATED; DIETARY SUPPLEMENTS; HUMANS; INFLAMMATION; NEOPLASMS; NEUROPROTECTIVE AGENTS; OBESITY; PAIN; PRIMARY PREVENTION; RISK REDUCTION BEHAVIOR; VITAMINS;

EID: 33644816310     PISSN: 10786791     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Nicklas BJ, Ambrosius W, Messier SP, et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr. 2004;79:544-551.
2. James MJ, Gibson RA, Cleland LG. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 2000;71(1 Suppl):343S-8S.
3. Simopoulos AP. Evolutionary aspects of omega-3 fatty acids in the food supply. Prostaglandins Leukot Essent Fatty Acids. 1999;60:421-429.
4. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21:495-505.
5. Berbert AA, Kondo CR, Almendra CL, Matsuo T, Dichi I. Supplementation of fish oil and olive oil in patients with rheumatoid arthritis. Nutrition. 2005;21:131-136.
6. Cleland LG, James MJ. Fish oil and rheumatoid arthritis: antiinflammatory and collateral health benefits. J Rheumatol. 2000;27:2305-2307.
7. Andersen-Ranberg K, Schroll M, Jeune B. Healthy centenarians do not exist, but autonomous centenarians do: a population-based study of morbidity among Danish centenarians. J Am Geriatr Soc. 2001;49:900-908.
8. Bruunsgaard H, Andersen-Ranberg K, Jeune B, Pedersen AN, Skinhoj P, Pedersen BK. A high plasma concentration of TNF-alpha is associated with dementia in centenarians. J Gerontol A Biol Sci Med Sci. 1999;54:M357-M364.
9. Bruunsgaard H, Pedersen BK. Age-related inflammatory cytokines and disease. Immunol Allergy Clin North Am. 2003;23:15-39.
10. Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA. Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2004;13:279-284.
11. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology. 2005;128:1567-1578.
12. Chong ZZ, Li F, Maiese K, Oxidative stress in the brain: novel cellular targets that govern survival during neurodegeneratrve disease. Prog Neurobiol. 2005. 75(3):207-246.
13. Gupta A, Watkins A, Thomas P, et al. Coagulation and inflammatory markers in Alzheimer's and vascular dementia. Int J Clin Pract. 2005;59:52-57.
14. Berg AH, Scherer PE. Adipose tissue, inflammation, and cardiovascular disease. Circ Res. 2005;96:939-949.
15. Lowe GD. The relationship between infection, inflammation, and cardiovascular disease: an overview. Ann Periodontol. 2001;6:1-8.
16. Reilly MP, Iqbal N, Schutta M, et al. Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. J Clin Endocrinol Metab. 2004;89:3872-3878.
17. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem. 1999;265:501-523.
18. Pischon T, Girman CJ, Hotamisligil GS, et al. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004;291:1730-1737.
19. Ouchi N, Kihara S, Funahashi T, et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation. 2003;107:671-674.
20. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr. Lenfant C; National Heart, Lung, and Blood Institute; American Heart Association. Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Arterioscler Thromb Vasc Biol. 2004;24:e13-e18.
21. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818-2825.
22. Niklason A, Hedner T, Niskanen L, Lanke J; Captoprrl Prevention Project Study Group. Development of diabetes is retarded by ACE inhibition in hypertensive patients-a sub-analysis of the Captopril Prevention Project (CAPPP). J Hypertens. 2004;22:645-652.
23. van Harmelen V, Skurk T, Rohrig K, Hauner H. HMG-CoA reductase inhibitor cerivastatin inhibits interleukin-6 expression and secretion in human adipocytes. Horm Metab Res. 2003;35:466-470.
24. Spiller RC. Inflammation as a basis for functional GI disorders. Best Pract Res Clin Gastroenterol. 2004;18:641-61.
25. Hinz B, Brune K. Pain and osteoarthritis: new drugs and mechanisms. Curr Opin Rheumatol. 2004;16:628-633.
26. Bonnet CS, Walsh DA. Osteoarthritis, angrogenesis and inflammation. Rheumatology. 2005;44:7-16.
27. Maxwell SR, Webb DJ. COX-2 selective inhibitors-important lessons learned. Lancet. 2005;365:449-51.
28. Bombardier C, Laine L, Reicin A, et al. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med. 2000;343:1520-1528.
29. Silverstein FE, Faich G, Goldstein JL, et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA. 2000;284:1247-1255.
30. Graham DJ, Campen D, Hui R, et al. Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control study. Lancet. 2005;365:475-481.
31. Pezzato E, Sartor L, Dell'Aica I, et al. Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate. Int J Cancer. 2004;112:787-792.
32. Gupta S, Ahmad N, Mukhtar H. Prostate cancer chemoprevention by green tea. Semin Urol Oncol. 1999;17:70-76.
33. Jian L, Xie LP, Lee AH, Binns CW. Protective effect of green tea against prostate cancer: a case-control study in southeast China. Int J Cancer. 2004;108:130-135.
34. Mayland C, Allen KR, Degg TJ, Bennet M. Micronutrient concentrations in patients with malignant disease: effect of the inflammatory response. Ann Clin Biochem. 2004;41(Pt 2):138-141.
35. Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA. 2005;102:14813-14818.
36. Giri RK, Rajagopal V, Kalra VK. Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J Neurochem. 2004;91:1199-1210.
37. Weinreb O, Mandel S, Amit T, Youdim MB. Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases. J Nutr Biohem. 2004;15:506-516.
38. Ames BN, Liu J. Delaying the mitochondrial decay of aging with acetylcarnitine. Ann N Y Acad Sci. 2004;1033:108-116.
39. Mozaffarian D, Pischon T, Hankinson SE, et al. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr. 2004;79:606-612.
40. Barzi F, Woodward M, Marfisi RM, et al. GISSI-Prevenzione Investigators. Mediterranean diet and all-causes mortality after myocardial infarction: results from the GISSI-Prevenzione trial. Eur J Clin Nutr. 2003;57:604-11.
41. Erratum in: Eur J Clin Nutr. 2003;57:1034.
42. King DE. Dietary fiber, inflammation, and cardiovascular disease. Mol Nutr Food Res. 2005;49:594-600.
43. Rimm EB, Ascherio A, Giovannucci E, et al. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA. 1996;275:447-451.
44. Harris WS. Extending the Cardiovascular Benefits of Omega-3 Fatty Acids. Curr Atheroscler Rep. 2005;7:375-380.
45. Boehnke C, Reuter U, Flach U, et al. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre. Eur J Neurol. 2004;11:475-477.
46. Pothmann R, Danesch U. Migraine prevention in children and adolescents: results of an open study with a special butterbur root extract. Headache. 2005;45:196-203.
47. Lipton RB, Gobel H, Einhaupl KM, Wilks K, Mauskop A. Petasites hybridus root (butter-bur) is an effective preventive treatment for migraine. Neurology. 2004;63:2240-2244.
48. Phan PV, Sohrabi A, Polotsky A, et al. Ginger extract components suppress induction of chemokine expression in human synoviocytes. J Altern Complement Med. 2005;11:149-154.